Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy
about
Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells.North African Medicinal Plants Traditionally Used in Cancer Therapy.The Role of Pontin and Reptin in Cellular Physiology and Cancer Etiology.Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma.Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a.CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer.Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promoter region (TPR)-dynein interaction.Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma.Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro.Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3
P2860
Q33618479-44B38D98-BE34-46CE-B7A3-399329150814Q37687091-E96E3636-118A-4DF8-9E66-9CECDF20DA12Q39427056-5EE758EE-B8F0-4A55-BC50-0F8BE5589F7BQ41539424-A80566D0-E6C7-47C5-8115-AB7744549BCAQ47860042-2ECD8231-47AB-4141-A5B5-8E8216841FB9Q47954143-FC4C638E-D31D-434E-8FAF-FE27FEA041DDQ47976317-DD7372D7-4A93-4AC1-999D-5752DCC9066BQ52431407-9B224748-2524-4FC7-BEE1-761939D9F22AQ52641585-DA9B9E1F-6770-4E39-B652-3C8C269900CCQ52694975-0D709059-4925-4D18-B0C7-6C2FBF9E32FDQ54110507-030A3A58-69FC-40EE-9A28-F8F8BA12A279Q55003938-0A6BF517-2453-4966-8F66-1A1AD87101B1Q58701699-8484B77B-E924-4695-9C0D-01DAB5EC8B0F
P2860
Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@ast
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@en
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@nl
type
label
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@ast
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@en
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@nl
prefLabel
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@ast
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@en
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Glycogen synthase kinase-3β is ...... sion and resistance to therapy
@en
P2093
Masahiro Uehara
Mitsutoshi Nakada
Takahiro Domoto
Takeo Shimasaki
Takuya Furuta
Toshinari Minamoto
P2860
P304
P3181
P356
10.1111/CAS.13028
P5008
P577
2016-09-24T00:00:00Z